In this regard, iron chelation exerts a direct neuroprotective effect in AD by avoiding the iron-mediated promotion of amyloid and tau pathology, through the mechanisms detailed above [93,95,96,116]. The gene discussed is MAPT; the disease is Alzheimer disease.